Chronic Kidney Disease (CKD) Market - Global Outlook and Forecast 2023-2028

Report ID: 1091565 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

This report contains market size and forecasts of Chronic Kidney Disease (CKD) in Global, including the following market information:
Global Chronic Kidney Disease (CKD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Kidney Disease (CKD) market was valued at 91100 million in 2021 and is projected to reach US$ 113470 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ACE Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Kidney Disease (CKD) include AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson and Keryx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Kidney Disease (CKD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Kidney Disease (CKD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Kidney Disease (CKD) Market Segment Percentages, by Type, 2021 (%)
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global Chronic Kidney Disease (CKD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chronic Kidney Disease (CKD) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Global Chronic Kidney Disease (CKD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chronic Kidney Disease (CKD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Kidney Disease (CKD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Kidney Disease (CKD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva

Frequently Asked Questions
Chronic Kidney Disease Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Kidney Disease Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Kidney Disease Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports